CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME
Sarcoidosis is a disorder of unknown etiology characterized by development of necrosis-free epithelioid cell granulomas in various tissues. There are two main phenotypes of pulmonary sarcoidosis (PS): Lofgren’s syndrome (LS) is an acute form with favorable outcome, while non-Lofgren’s syndrome (nLS)...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | RU |
| Publicado: |
SPb RAACI
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6b7c030954df40b3ba1281b68c28aa24 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6b7c030954df40b3ba1281b68c28aa24 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6b7c030954df40b3ba1281b68c28aa242021-11-18T08:03:48ZCD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME1563-06252313-741X10.15789/1563-0625-2019-3-467-478https://doaj.org/article/6b7c030954df40b3ba1281b68c28aa242019-07-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1820https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XSarcoidosis is a disorder of unknown etiology characterized by development of necrosis-free epithelioid cell granulomas in various tissues. There are two main phenotypes of pulmonary sarcoidosis (PS): Lofgren’s syndrome (LS) is an acute form with favorable outcome, while non-Lofgren’s syndrome (nLS) is a chronic type of disease that can lead to pulmonary fibrosis in 20% of cases.Our study was aimed at investigating changes in the main cell-surface differentiation antigens on peripheral blood regulatory T cells (Tregs) from the patients with first diagnosed PS without treatment (LS, n = 11) and nLS (n = 46) compared to healthy volunteers (HC, n = 26).These indexes might be used as immunological markers for predicting severity of this disorder. Flow cytometry analysis of peripheral blood cell samples demonstrated that the nLS patients had decreased relative numbers of CD3+ cells vs healthy controls, as well as diminished CD3+CD4+ cells vs HC and LS patients. Furthermore, the relative and absolute Treg numbers were also decreased in nLS group vs HC (2.83% (2.47; 3.36) vs 3.33% (2.79; 3.84), p = 0.021), and 37 (29; 52) cells vs 50 (42; 65), p = 0.004, respectively) per one microliter of peripheral blood. Relative number of CD39-positive Тregs in chronic vs acute sarcoidosis patients was associated with 51.02% (38.20; 61.62) vs 48.64% (41.46; 63.72) that was significantly (p < 0.001 and p = 0.007, respectively) higher than in HC (39.52% (11.55; 46.34). We have found that “naïve” (CD45R0-CD62L+) Тregs did not significantly differ in percentage of CD39- and CD73-positive cells in all the groups tested. Moreover, CD45R0+CD62L+ Тregs in LS and nLS patients contained significantly more CD39-positive cells (69.66% (61.92; 79.34) and 67.62% (61.92; 79.34), respectively, compared to 47.55% (15.74; 65.32) in HC (p < 0.001 and p = 0.004, respectively). In case of CD45R0 + CD62LTregs able to exit from the circulation and migrate to the site of inflammation, an increased percentage of CD39-positive subset was noted only in patients with chronic sarcoidosis and HC (61.79% (55.12; 73.09) and 57.27% (16.03; 66.98), p = 0.006). Enhanced CD39 expression on Tregs seems to be related to chronic immune response, so that antigen elimination becomes impossible due to Treg overactivation, as shown in patients with sarcoidosis and some other chronic autoimmune and infectious disorders.I. V. KudryavtsevN. M. LazarevaO. P. BaranovaA. S. GolovkinD. V. IsakovM. K. SerebriakovaT. P. Ses’M. M. IlkovichAreg A. TotolianSPb RAACIarticlesarcoidosisregulatory t cellscd39 expressionflow cytometrymulti-color immunophenotypingImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 21, Iss 3, Pp 467-478 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
RU |
| topic |
sarcoidosis regulatory t cells cd39 expression flow cytometry multi-color immunophenotyping Immunologic diseases. Allergy RC581-607 |
| spellingShingle |
sarcoidosis regulatory t cells cd39 expression flow cytometry multi-color immunophenotyping Immunologic diseases. Allergy RC581-607 I. V. Kudryavtsev N. M. Lazareva O. P. Baranova A. S. Golovkin D. V. Isakov M. K. Serebriakova T. P. Ses’ M. M. Ilkovich Areg A. Totolian CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME |
| description |
Sarcoidosis is a disorder of unknown etiology characterized by development of necrosis-free epithelioid cell granulomas in various tissues. There are two main phenotypes of pulmonary sarcoidosis (PS): Lofgren’s syndrome (LS) is an acute form with favorable outcome, while non-Lofgren’s syndrome (nLS) is a chronic type of disease that can lead to pulmonary fibrosis in 20% of cases.Our study was aimed at investigating changes in the main cell-surface differentiation antigens on peripheral blood regulatory T cells (Tregs) from the patients with first diagnosed PS without treatment (LS, n = 11) and nLS (n = 46) compared to healthy volunteers (HC, n = 26).These indexes might be used as immunological markers for predicting severity of this disorder. Flow cytometry analysis of peripheral blood cell samples demonstrated that the nLS patients had decreased relative numbers of CD3+ cells vs healthy controls, as well as diminished CD3+CD4+ cells vs HC and LS patients. Furthermore, the relative and absolute Treg numbers were also decreased in nLS group vs HC (2.83% (2.47; 3.36) vs 3.33% (2.79; 3.84), p = 0.021), and 37 (29; 52) cells vs 50 (42; 65), p = 0.004, respectively) per one microliter of peripheral blood. Relative number of CD39-positive Тregs in chronic vs acute sarcoidosis patients was associated with 51.02% (38.20; 61.62) vs 48.64% (41.46; 63.72) that was significantly (p < 0.001 and p = 0.007, respectively) higher than in HC (39.52% (11.55; 46.34). We have found that “naïve” (CD45R0-CD62L+) Тregs did not significantly differ in percentage of CD39- and CD73-positive cells in all the groups tested. Moreover, CD45R0+CD62L+ Тregs in LS and nLS patients contained significantly more CD39-positive cells (69.66% (61.92; 79.34) and 67.62% (61.92; 79.34), respectively, compared to 47.55% (15.74; 65.32) in HC (p < 0.001 and p = 0.004, respectively). In case of CD45R0 + CD62LTregs able to exit from the circulation and migrate to the site of inflammation, an increased percentage of CD39-positive subset was noted only in patients with chronic sarcoidosis and HC (61.79% (55.12; 73.09) and 57.27% (16.03; 66.98), p = 0.006). Enhanced CD39 expression on Tregs seems to be related to chronic immune response, so that antigen elimination becomes impossible due to Treg overactivation, as shown in patients with sarcoidosis and some other chronic autoimmune and infectious disorders. |
| format |
article |
| author |
I. V. Kudryavtsev N. M. Lazareva O. P. Baranova A. S. Golovkin D. V. Isakov M. K. Serebriakova T. P. Ses’ M. M. Ilkovich Areg A. Totolian |
| author_facet |
I. V. Kudryavtsev N. M. Lazareva O. P. Baranova A. S. Golovkin D. V. Isakov M. K. Serebriakova T. P. Ses’ M. M. Ilkovich Areg A. Totolian |
| author_sort |
I. V. Kudryavtsev |
| title |
CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME |
| title_short |
CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME |
| title_full |
CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME |
| title_fullStr |
CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME |
| title_full_unstemmed |
CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME |
| title_sort |
cd39<sup>+</sup> expression by regulatory t cells in pulmonary sarcoidosis and lofgren’s syndrome |
| publisher |
SPb RAACI |
| publishDate |
2019 |
| url |
https://doaj.org/article/6b7c030954df40b3ba1281b68c28aa24 |
| work_keys_str_mv |
AT ivkudryavtsev cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT nmlazareva cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT opbaranova cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT asgolovkin cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT dvisakov cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT mkserebriakova cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT tpses cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT mmilkovich cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome AT aregatotolian cd39supsupexpressionbyregulatorytcellsinpulmonarysarcoidosisandlofgrenssyndrome |
| _version_ |
1718422357222096896 |